Related references
Note: Only part of the references are listed.Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population
Fitsum Sebsibe Teni et al.
QUALITY OF LIFE RESEARCH (2022)
Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program
Guy Van Vliet et al.
M S-MEDECINE SCIENCES (2021)
The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
Alice Bessey et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2020)
Health utilities and parental quality of life effects for three rare conditions tested in newborns
Norma-Jean Simon et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2019)
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
Scott D. Grosse
HEALTHCARE (2015)
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: Results from a decision-analytic model
Lauren E. Cipriano et al.
VALUE IN HEALTH (2007)
Comprehensive cost-utility analysis of newborn screening strategies
AE Carroll et al.
PEDIATRICS (2006)
Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism
EA Geelhoed et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2005)